444 related articles for article (PubMed ID: 9366621)
41. High incidence of second basal cell skin cancers.
Levi F; Randimbison L; Maspoli M; Te VC; La Vecchia C
Int J Cancer; 2006 Sep; 119(6):1505-7. PubMed ID: 16642479
[TBL] [Abstract][Full Text] [Related]
42. Risk of a new primary cancer among patients with lung cancer of different histological types.
Teppo L; Salminen E; Pukkala E
Eur J Cancer; 2001 Mar; 37(5):613-9. PubMed ID: 11290437
[TBL] [Abstract][Full Text] [Related]
43. Occurrence of other cancers among patients with prior basal cell and squamous cell skin cancer.
Karagas MR; Greenberg ER; Mott LA; Baron JA; Ernster VL
Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):157-61. PubMed ID: 9488591
[TBL] [Abstract][Full Text] [Related]
44. Body site specific incidence of basal and squamous cell carcinoma in an exposed population, Townsville, Australia.
Raasch B; Maclennan R; Wronski I; Robertson I
Mutat Res; 1998 Nov; 422(1):101-6. PubMed ID: 9920433
[TBL] [Abstract][Full Text] [Related]
45. Use of Radioactive Iodine for Thyroid Cancer and Risk of Second Primary Malignancy: A Nationwide Population-Based Study.
Teng CJ; Hu YW; Chen SC; Yeh CM; Chiang HL; Chen TJ; Liu CJ
J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26538627
[TBL] [Abstract][Full Text] [Related]
46. Increased risk of second malignant neoplasms outside radiation fields in patients with cervical carcinoma.
Werner-Wasik M; Schmid CH; Bornstein LE; Madoc-Jones H
Cancer; 1995 May; 75(9):2281-5. PubMed ID: 7712437
[TBL] [Abstract][Full Text] [Related]
47. Skin cancer risk among solid organ recipients: a nationwide cohort study in Denmark.
Jensen AO; Svaerke C; Farkas D; Pedersen L; Kragballe K; Sørensen HT
Acta Derm Venereol; 2010 Sep; 90(5):474-9. PubMed ID: 20814621
[TBL] [Abstract][Full Text] [Related]
48. Trends in skin cancer incidence in Vaud: an update, 1976-1998.
Levi F; Te VC; Randimbison L; Erler G; La Vecchia C
Eur J Cancer Prev; 2001 Aug; 10(4):371-3. PubMed ID: 11535880
[TBL] [Abstract][Full Text] [Related]
49. Second primary cancers in patients with squamous cell carcinoma of the skin.
Maitra SK; Gallo H; Rowland-Payne C; Robinson D; Møller H
Br J Cancer; 2005 Feb; 92(3):570-1. PubMed ID: 15611792
[TBL] [Abstract][Full Text] [Related]
50. The risk of developing a second, different, cancer among 14 560 survivors of malignant cutaneous melanoma: a study by AIRTUM (the Italian Network of Cancer Registries).
Crocetti E; Guzzinati S; Paci E; Falcini F; Zanetti R; Vercelli M; Rashid I; De Lisi V; Russo A; Vitarelli S; Ferretti S; Mangone L; Cesaraccio R; Tumino R; Pannozzo F
Melanoma Res; 2008 Jun; 18(3):230-4. PubMed ID: 18477899
[TBL] [Abstract][Full Text] [Related]
51. Incidence and risk factors associated with a second squamous cell carcinoma or basal cell carcinoma in psoralen + ultraviolet a light-treated psoriasis patients.
Katz KA; Marcil I; Stern RS
J Invest Dermatol; 2002 Jun; 118(6):1038-43. PubMed ID: 12060400
[TBL] [Abstract][Full Text] [Related]
52. Malignant melanoma and nonmelanoma skin cancers in Northrhine-Westphalia, Germany: a patient- vs. diagnosis-based incidence approach.
Stang A; Ziegler S; Büchner U; Ziegler B; Jöckel KH; Ziegler V
Int J Dermatol; 2007 Jun; 46(6):564-70. PubMed ID: 17550552
[TBL] [Abstract][Full Text] [Related]
53. Re: detection of Epstein-Barr virus in invasive breast cancers.
Hemminki K; Dong C
J Natl Cancer Inst; 1999 Dec; 91(24):2126; author reply 2127. PubMed ID: 10601385
[No Abstract] [Full Text] [Related]
54. Malignancies diagnosed before and after anal squamous cell carcinomas: A SEER registry analysis.
Jani KS; Lu SE; Murphy JD; Romesser PB; Jethwa KR; Li D; Chundury A; Wu AJ; Hathout L; Hallemeier CL; Jabbour SK
Cancer Med; 2021 Jun; 10(11):3575-3583. PubMed ID: 33960690
[TBL] [Abstract][Full Text] [Related]
55. [New cancers after squamous cell skin cancer].
Frisch M; Melbye M
Ugeskr Laeger; 1996 Feb; 158(8):1079-83. PubMed ID: 8638342
[TBL] [Abstract][Full Text] [Related]
56. Second primary cancers in patients with skin cancer: a population-based study in Northern Ireland.
Cantwell MM; Murray LJ; Catney D; Donnelly D; Autier P; Boniol M; Fox C; Middleton RJ; Dolan OM; Gavin AT
Br J Cancer; 2009 Jan; 100(1):174-7. PubMed ID: 19127269
[TBL] [Abstract][Full Text] [Related]
57. The association between malignant melanoma and noncutaneous malignancies.
Wu YH; Kim GH; Wagner JD; Hood AF; Chuang TY
Int J Dermatol; 2006 May; 45(5):529-34. PubMed ID: 16700785
[TBL] [Abstract][Full Text] [Related]
58. Cancer risk in women with previous breast cancer.
Levi F; Te VC; Randimbison L; La Vecchia C
Ann Oncol; 2003 Jan; 14(1):71-3. PubMed ID: 12488295
[TBL] [Abstract][Full Text] [Related]
59. Second primary cancers in patients with cutaneous malignant melanoma: a population-based study in Sweden.
Wassberg C; Thörn M; Yuen J; Ringborg U; Hakulinen T
Br J Cancer; 1996 Jan; 73(2):255-9. PubMed ID: 8546916
[TBL] [Abstract][Full Text] [Related]
60. Skin cancer incidence among atomic bomb survivors from 1958 to 1996.
Sugiyama H; Misumi M; Kishikawa M; Iseki M; Yonehara S; Hayashi T; Soda M; Tokuoka S; Shimizu Y; Sakata R; Grant EJ; Kasagi F; Mabuchi K; Suyama A; Ozasa K
Radiat Res; 2014 May; 181(5):531-9. PubMed ID: 24754560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
